Wegovy (Novo Nordisk) Patient Support Program Eligibility: Must have private insurance that covers Wegovy, not receiving government drug benefits Savings: Up to $150 per monthly prescription for 12 months Maximum annual benefit: $1,800 How it works: Reduces out-of-pocket costs after insurance pays their portion Saxenda (Novo Nordisk) Patient Support Program Eligibility: Private insurance covering Saxenda, not on provincial drug plans Savings: Up to $120 per monthly prescription Maximum annual benefit: $1,440 How it works: Applied at pharmacy, reduces copay amount Expected Retatrutide Program (Not Yet Announced) Projected eligibility: Private insurance with Retatrutide coverage, not receiving provincial benefits Projected savings: $200-300 per monthly prescription based on medication cost Projected maximum benefit: $2,400-3,600 annually Expected launch: Same time as Health Canada approval The catch with Canadian savings programs: you need private insurance that already covers the medication
These observations highlight the intricate pathophysiology underlying the role of myelin in the progression of AD progression
By mimicking GLP-1 and GIP hormones, it helps manage blood sugar and suppress appetite, leading to substantial weight loss for many patients
That's why we focus on comprehensive treatment: the medication jumpstarts weight loss, while lifestyle changes and metabolic improvements help maintain results
Differential dependence on cysteine from Transsulfuration versus transport during T cell activation
Recovery support is essential for long-term performance Training and physical activity place ongoing stress on: Muscles Tendons Ligaments Connective tissues Supporting recovery pathways helps contribute to: Better routine consistency Improved structural support Greater resilience under physical demand Connective tissues recover differently Tendons and ligaments naturally have more limited blood supply than muscle tissue, which may influence how efficiently they recover from strain and repetitive stress
